Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Psychiatry ; 21(4): 574-84, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26303660

ABSTRACT

Latency-reversing agents (LRAs), including histone deacetylase inhibitors (HDACi), are being investigated as a strategy to eliminate latency in HIV-infected patients on suppressive antiretroviral therapy. The effectiveness of LRAs in activating latent infection in HIV strains derived from the central nervous system (CNS) is unknown. Here we show that CNS-derived HIV-1 strains possess polymorphisms within and surrounding the Sp transcription factor motifs in the long terminal repeat (LTR). These polymorphisms result in decreased ability of the transcription factor specificity protein 1 to bind CNS-derived LTRs, reducing the transcriptional activity of CNS-derived viruses. These mutations result in CNS-derived viruses being less responsive to activation by the HDACi panobinostat and romidepsin compared with lymphoid-derived viruses from the same subjects. Our findings suggest that HIV-1 strains residing in the CNS have unique transcriptional regulatory mechanisms, which impact the regulation of latency, the consideration of which is essential for the development of HIV-1 eradication strategies.


Subject(s)
Brain/virology , HIV Infections/virology , HIV-1/physiology , Histone Deacetylase Inhibitors/therapeutic use , Adult , Brain/metabolism , CD4-Positive T-Lymphocytes , Central Nervous System/metabolism , Cohort Studies , Depsipeptides/pharmacology , HIV Infections/drug therapy , HIV-1/genetics , Humans , Hydroxamic Acids/pharmacology , Indoles/pharmacology , Jurkat Cells , Male , Middle Aged , Panobinostat , Polymorphism, Genetic , Terminal Repeat Sequences , Transcriptional Activation , Virus Latency/drug effects
2.
J Virol ; 75(21): 10073-89, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11581376

ABSTRACT

The viral determinants that underlie human immunodeficiency virus type 1 (HIV-1) neurotropism are unknown, due in part to limited studies on viruses isolated from brain. Previous studies suggest that brain-derived viruses are macrophage tropic (M-tropic) and principally use CCR5 for virus entry. To better understand HIV-1 neurotropism, we isolated primary viruses from autopsy brain, cerebral spinal fluid, blood, spleen, and lymph node samples from AIDS patients with dementia and HIV-1 encephalitis. Isolates were characterized to determine coreceptor usage and replication capacity in peripheral blood mononuclear cells (PBMC), monocyte-derived macrophages (MDM), and microglia. Env V1/V2 and V3 heteroduplex tracking assay and sequence analyses were performed to characterize distinct variants in viral quasispecies. Viruses isolated from brain, which consisted of variants that were distinct from those in lymphoid tissues, used CCR5 (R5), CXCR4 (X4), or both coreceptors (R5X4). Minor usage of CCR2b, CCR3, CCR8, and Apj was also observed. Primary brain and lymphoid isolates that replicated to high levels in MDM showed a similar capacity to replicate in microglia. Six of 11 R5 isolates that replicated efficiently in PBMC could not replicate in MDM or microglia due to a block in virus entry. CD4 overexpression in microglia transduced with retroviral vectors had no effect on the restricted replication of these virus strains. Furthermore, infection of transfected cells expressing different amounts of CD4 or CCR5 with M-tropic and non-M-tropic R5 isolates revealed a similar dependence on CD4 and CCR5 levels for entry, suggesting that the entry block was not due to low levels of either receptor. Studies using TAK-779 and AMD3100 showed that two highly M-tropic isolates entered microglia primarily via CXCR4. These results suggest that HIV-1 tropism for macrophages and microglia is restricted at the entry level by a mechanism independent of coreceptor specificity. These findings provide evidence that M-tropism rather than CCR5 usage predicts HIV-1 neurotropism.


Subject(s)
Brain/virology , HIV-1/physiology , Lymphoid Tissue/virology , Macrophages/virology , Microglia/virology , Receptors, HIV/physiology , Amino Acid Sequence , CD4 Antigens/analysis , Gene Products, env/chemistry , Humans , Leukocytes, Mononuclear/virology , Molecular Sequence Data , Polymerase Chain Reaction , Receptors, CCR5/analysis , Receptors, CCR5/physiology , Receptors, CXCR4/physiology , Virus Replication
3.
J Virol ; 73(1): 352-61, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9847339

ABSTRACT

Astrocytes infected with human immunodeficiency virus type 1 (HIV-1) produce only minimal quantities of virus. The molecular events that limit acute-phase HIV-1 infection of astrocytes were examined after inducing acute-phase replication by transfection with the pNL4-3 proviral plasmid. The levels of HIV-1 mRNA were similarly high in both astrocytes and HeLa cells, but astrocytes produced approximately 50-fold less supernatant p24 than HeLa cells. We found that diminished HIV-1 production in astrocytes resulted from inefficient translation of gag, env, and nef mRNAs that were efficiently transported to the cytoplasm. Tat- or Rev-dependent reporter constructs showed no defect in Tat or Rev function in astrocytes compared with HeLa cells. HIV-1 mRNAs were correctly spliced, but only Rev and Tat proteins were efficiently translated from their native mRNAs. Pulse-chase labelling and immunoblot experiments revealed no defect in protein processing, but levels of Gag, Env, or Nef protein expressed were dramatically reduced in astrocytes compared to HeLa cells. These results demonstrate that inefficient translation of HIV-1 structural proteins underlies the restricted infection of astrocytes. The efficient expression of functional Tat and Rev by astrocytes may contribute to HIV-1 neuropathogenesis.


Subject(s)
Astrocytes/virology , Gene Products, rev/biosynthesis , Gene Products, tat/biosynthesis , HIV-1/physiology , Protein Biosynthesis , RNA, Messenger/analysis , 5' Untranslated Regions , Gene Products, env/biosynthesis , Gene Products, gag/biosynthesis , Gene Products, nef/biosynthesis , HIV Core Protein p24/biosynthesis , Humans , Tumor Cells, Cultured , nef Gene Products, Human Immunodeficiency Virus , rev Gene Products, Human Immunodeficiency Virus , tat Gene Products, Human Immunodeficiency Virus
SELECTION OF CITATIONS
SEARCH DETAIL
...